Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

831.5500 0.05 (0.01%)

NSE Aug 12, 2025 15:27 PM

99.08% Gain from 52W Low

Volume: 1.8M

Laurus Labs Ltd.

29 Apr 2022

831.55

0.01%

Laurus Labs (HOLD): Mixed Q4; non-ARV business guided to drive $1bn in sales

Hold: Laurus Labs Ltd.

Target

BOB Capital Markets Ltd.

Q4 topline growth 14% ahead of consensus as healthy CDMO, FDF and non-ARV API sales offset decline in ARV business

Number of FII/FPI investors increased from 259 to 293 in Jun 2025 qtr.